The Kaplan-Meier survival analyses of The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlases (CGGA325 and CGGA693) revealed that high CD13 expression is associated with a significantly shorter survival of glioma patients. This evidence concerns the gene ANPEP and glioma.